Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to enable the next generation of molecularly targeted therapeutics, announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply UNP’s technology to design and develop macrocyclic candidates against an oncology therapeutic target.